Bulk APIs

Chemi SPA, born as Chemical branch of Italfarmaco SPA, is specialized in the development and production of Active Pharmaceutical Ingredients.

Extensive continuous investment in R&D enabled Chemi to become leader in Development and production of standard and injectable grade APIs, highly sophisticated molecules such as Low Molecular Weight Heparins, polysaccharide derivatives, oncology products, Peptides and Phospholipids.

Chemi provides unique IP assets that protect its product portfolio.

Headquartered in Cinisello Balsamo Milano, Chemi’s state-of-the-art production facilities state are located in in Patrica (Italy), Cinisello (Italy), Camaçari (Brazil). All plants are regularly FDA inspected, GMP compliant and certified by the Regulatory Agencies of different Countries.

PATRICA ITALY FDA inspected plant

  • Sodium Alendronate
  • Alpha GPC (alpha–GlycerylPhosphorylCholine)
  • Benserazide
  • Bupropion
  • Diflunisal
  • Flunarizine
  • Mesalazine
  • Nabumetone
  • Paroxetine HCl Hemihydrate
  • Sodium Risedronate
  • Sodium Ibandronate
  • Trimetazidine

CAMAÇARI BRAZIL FDA inspected plant

  • Iron Protein Succinylate
  • Paroxetine HCl Hemihydrate
  • Sevelamer HCl and Carbonate
  • Colesevelam
Products currently covered by valid Patents are offered for R&D purposes only

CAMAÇARI BRAZIL FDA inspected plant

  • Azacitidine
  • Bendamustine
  • Decitabine
  • Pemetrexed
  • Temozolomide

UNDER DEVELOPMENT

  • Bortezomib
  • Belinostat
  • Cyclophosphamide
  • Melphalan
Products currently covered by valid Patents are offered for R&D purposes only

PATRICA ITALY FDA inspected plant
N-Oleoyl-Phosphatidyl-Ethanolamine (NOPE)

  • 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PhosphoGlycerol POPG
  • 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PhosphoCholine POPC
  • 1,2-DiArachidoyl-sn-glycero-3-PhosphoCholine DAPC
  • 1,2-DiMyristoyl-sn-glycero-3-PhosphoCholine DMPC
  • 1,2-DiPalmitoyl-sn-glycero-3-PhosphoCholine DPPC

CAMAÇARI BRAZIL FDA inspected plant

  • Phosphatidylserine PS
  • Phosphatidic acid
Products currently covered by valid Patents are offered for R&D purposes only